Calcitriol and vitamin D3 analogs suppress the secretion of proteolytic enzymes in breast and prostate cancer cells while also inhibiting the expression of receptors of cell-adhesion molecules, e.g., vascular cell-adhesion protein 1 (VCAM-1) [117]. The gene discussed is VCAM1; the disease is prostate carcinoma.